Downregulation of adipose triglyceride lipase by EB viral-encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma.
Shixing ZhengLiudmila MatskovaXiaoying ZhouXue XiaoGuangwu HuangZhe ZhangIngemar ErnbergPublished in: Molecular oncology (2020)
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is one of the most common human cancers in South-East Asia exhibiting typical features of lipid accumulation. EBV-encoded latent membrane protein 2A (LMP2A) is expressed in most NPCs enhancing migration and invasion. We recently showed an increased accumulation of lipid droplets in NPC, compared with normal nasopharyngeal epithelium. It is important to uncover the mechanism behind this lipid metabolic shift to better understand the pathogenesis of NPC and provide potential therapeutic targets. We show that LMP2A increased lipid accumulation in NPC cells. LMP2A could block lipid degradation by downregulating the lipolytic gene adipose triglycerol lipase (ATGL). This is in contrast to lipid accumulation due to enhanced lipid biosynthesis seen in many cancers. Suppression of ATGL resulted in enhanced migration in vitro, and ATGL was found downregulated in NPC biopsies. The reduced expression level of ATGL correlated with poor overall survival in NPC patients. Our findings reveal a new role of LMP2A in lipid metabolism, correlating with NPC patient survival depending on ATGL downregulation.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- fatty acid
- end stage renal disease
- cell proliferation
- signaling pathway
- genome wide
- ejection fraction
- magnetic resonance
- endothelial cells
- induced apoptosis
- poor prognosis
- chronic kidney disease
- newly diagnosed
- insulin resistance
- peritoneal dialysis
- case report
- single cell
- oxidative stress
- long non coding rna
- metabolic syndrome
- prognostic factors
- skeletal muscle
- computed tomography
- contrast enhanced
- copy number
- cell death
- patient reported
- endoplasmic reticulum stress
- induced pluripotent stem cells
- low density lipoprotein